Nanobiotix S.A. (ADR)
General ticker "NBTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $354.5M (TTM average)
Nanobiotix S.A. (ADR) follows the US Stock Market performance with the rate: 50.2%.
Estimated limits based on current volatility of 2.6%: low 32.26$, high 34.00$
Factors to consider:
- Total employees count: 88 as of 2020
Short-term NBTX quotes
Long-term NBTX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €36.21MM | €0.00MM | €29.64MM |
| Operating Expenses | €62.99MM | €68.39MM | €40.46MM |
| Operating Income | €-26.78MM | €-68.39MM | €-10.82MM |
| Non-Operating Income | €-12.80MM | €0.36MM | €-13.14MM |
| Interest Expense | €7.98MM | €8.09MM | €10.39MM |
| R&D Expense | €38.40MM | €40.54MM | €23.11MM |
| Income(Loss) | €-39.58MM | €-68.03MM | €-23.96MM |
| Taxes | €0.12MM | €0.10MM | €0.00MM |
| Profit(Loss)* | €-39.70MM | €-68.13MM | €-23.96MM |
| Stockholders Equity | €-1.84MM | €-65.70MM | €-84.48MM |
| Inventory | €0.20MM | €0.00MM | €0.00MM |
| Assets | €93.90MM | €67.42MM | €67.76MM |
| Operating Cash Flow | €-12.48MM | €-19.55MM | €-33.42MM |
| Capital expenditure | €0.33MM | €0.85MM | €0.55MM |
| Investing Cash Flow | €-0.35MM | €-0.95MM | €-0.58MM |
| Financing Cash Flow | €46.77MM | €-5.13MM | €37.42MM |
| Earnings Per Share** | €-1.08 | €-1.44 | €-0.50 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.